Bliss GVS Pharma 대차 대조표 상태
재무 상태 기준 확인 6/6
Bliss GVS Pharma 의 총 주주 지분은 ₹10.5B 이고 총 부채는 ₹832.9M, 이는 부채 대 자기자본 비율을 7.9% 로 가져옵니다. 총자산과 총부채는 각각 ₹12.8B 및 ₹2.3B 입니다. Bliss GVS Pharma 의 EBIT는 ₹1.2B 이며 이자보상배율은 -36.2 입니다. ₹2.2B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
7.9%
부채 비율
₹832.88m
부채
이자 보상 비율 | -36.2x |
현금 | ₹2.20b |
주식 | ₹10.48b |
총 부채 | ₹2.34b |
총 자산 | ₹12.83b |
최근 재무 상태 업데이트
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Recent updates
Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel
Nov 23Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors
Oct 26These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06재무 상태 분석
단기부채: BLISSGVS 의 단기 자산 ( ₹8.5B )이 단기 부채( ₹1.9B ).
장기 부채: BLISSGVS 의 단기 자산( ₹8.5B )이 장기 부채( ₹418.8M ).
부채 대 자본 내역 및 분석
부채 수준: BLISSGVS 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: BLISSGVS 의 부채 대 자기자본 비율은 지난 5년간 12.9% 에서 7.9% 로 감소했습니다.
부채 범위: BLISSGVS 의 부채는 영업 현금 흐름 ( 126.1% )에 의해 잘 충당되었습니다.
이자 보장: BLISSGVS 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.